Targeting Vector Design with Receptor Binding and Endosomal Escape
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current drug delivery vectors, including viral and non-viral vectors, face challenges in achieving specific delivery to target cells, particularly for bio-macromolecules, due to insufficient specificity and efficiency in recognizing and entering target cells.
Innovation Solution
A targeting vector is designed with a first molecule that binds to a specific endocytosis receptor of the target cell and a second molecule that promotes endosomal or lysosomal escape, using engineered viral or non-viral envelope proteins to enhance specificity and delivery efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If lentiviral vectors with VSVG envelope protein are used for broad cell infection, then infection efficiency is improved, but targeting specificity deteriorates
Solution Approach 1:
The envelope protein is divided into two functional segments: a first molecule (such as a peptide or antibody fragment) responsible for specific binding to endocytosis receptors on target cells, and a second molecule (fusion peptide) responsible for membrane fusion and viral entry. This segmentation allows each segment to optimize its specific function without interfering with the other, achieving both high specificity and high efficiency.
Solution Approach 2:
Different regions of the envelope protein are assigned different functional properties: the N-terminal region contains the first molecule with high affinity for specific endocytosis receptors (e.g., LDL-R, ASCT1, ASCT2), while the C-terminal region contains the second molecule with fusogenic activity. This local differentiation of functional quality enables precise targeting combined with efficient entry.
2Adaptability or versatility
If envelope proteins with broad receptor recognition are used, then versatility of cell types is improved, but infection specificity deteriorates
Solution Approach 1:
The second molecule (fusion peptide) provides universal fusogenic activity that works across different cell types, while the first molecule provides specific targeting. This multi-functionality allows the envelope protein to both target specific cells and efficiently enter a broad range of cell types that express the relevant endocytosis receptors.
3Productivity
If wild-type envelope proteins are used for viral entry, then entry efficiency is improved, but targeting accuracy deteriorates
Solution Approach 1:
The fusogenic function (second molecule) is extracted from the wild-type envelope protein and separated from the receptor-binding function. This allows the fusogenic activity to be preserved for efficient entry while replacing the receptor-binding region with a highly specific first molecule that targets endocytosis receptors, thereby improving targeting accuracy without sacrificing entry efficiency.
4Manufacturing precision
If lentiviral vectors are engineered with specific targeting molecules, then targeting specificity is improved, but device complexity deteriorates
Solution Approach 1:
The envelope protein is constructed as a composite molecule combining two distinct functional elements: a specific binding domain (first molecule) and a fusogenic domain (second molecule). This composite structure achieves high targeting specificity while maintaining relatively simple vector construction, as the dual-function envelope protein can be expressed from a single genetic cassette.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The targeting vector achieves precise delivery of substances to specific cells by utilizing endocytosis receptors and engineered envelope proteins, improving infection specificity and avoiding unintended cell infections.
Implementation Method 1
a first molecule that binds to an endocytosis receptor of a target cell
Implementation Method 2
a second molecule that promotes the release of a substance loaded on the targeting vector into cytoplasm
Data Source
Figure 1~2
Figure 3
Figure 4
AI summary
Provided are a targeting vector and a method for targeting same to a host cell. The vector comprises a first molecule that binds to an endocytosis receptor of the target cell and a second molecule that promotes the release of a substance carried by the targeting vector into a cytoplasm. When the targeting vector is a viral vector, the first molecule is not part of a viral envelope protein, and the second molecule promotes endosomal escape or lysosomal escape of the targeting vector. The first molecule is designed according to the endocytosis receptor of the cell to be targeted, different types of cells can be targeted, and after a reasonable mutation is carried out on the vector, infection of cells that do not need to be targeted can be avoided, thereby improving the accuracy of the vector.